1,557
Views
70
CrossRef citations to date
0
Altmetric
Review Article

Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques

, &
Pages 1401-1415 | Received 11 Sep 2014, Accepted 07 Feb 2015, Published online: 08 Apr 2015

References

  • Arunachalam A, Kathikeyan M, Konam K, et al. Solid dispersion: a Review. Curr Pharm Res 2010;1:82–90
  • Berge SM, Bighley LD, Monkhouse DC. Pharmaceutical salts. J Pharm Sci 1977;66:1–19
  • Gao ZG, Choi HG, Shin HJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm 1998;161:75–86
  • Calabro ML, Tommasini S, Donato P, et al. The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays. J Pharm Biomed Anal 2005;36:1019–27
  • Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev 2012;64:480–95
  • Cheow W, Hadinoto K. Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility. J Colloid Interface Sci 2012;367:518–26
  • Sotthivirata S, McKelveya C, Moserb J, et al. Development of amorphous solid dispersion formulations of a poorlywater-soluble drug, MK-0364. Int J Pharm 2013;452:73–81
  • Smithey PGD, Taylor LS. Amorphous solid dispersions: an enabling formulation technology for oral delivery of poorly water soluble drugs. AAPS Newsmag 2013;16:11–14
  • Vo CLN, Park C, Lee BJ. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm 2013;85:799–813
  • Al-Obaidi H, Buckton G. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. AAPS PharmSciTech 2009;10:1172–7
  • Andrews GP, AbuDiak OA, Jones DS. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J Pharm Sci 2010;99:1322–35
  • Jang WS, Kang MJ. Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique. Int J Pharm 2014;473:187–93
  • Kim Y, Kim KS, Suh KH, et al. New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs. Int J Pharm 2011;415:129–39
  • Li B, Harich K, Wegiel L, et al. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. Carbohydr Polym 2012;92:1443–50
  • Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–302
  • Arun G, Shweta P, Upendra KJ. Formulation and evaluation of ternary solid dispersion of curcumin. Int J Pharm Pharm Sci 2012;4:360–5
  • Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131–44
  • Patterson JE, James MB, Forster AH, et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm 2007;336:22–34
  • Vasconcelos T, Sarmento B, Costa P. Solid dispersions as a strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–75
  • Baird JA, Taylor LS. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev 2012;64:396–421
  • Drooge DJV, Hinrichs W, Visser M, Frijlink H. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm 2006;310:220–9
  • Reitz E, Vervaet C, Neubert RHH, Thommes M. Solid crystal suspensions containing griseofulvin – preparation and bioavailability testing. Eur J Pharma Biopharm 2013;83:193–202
  • Chiou WL, Riegelman S. Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J Pharm Sci 1969;58:1505–10
  • Zajc N, Obreza A, Bele M, Srcic S. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm 2005;291:51–8
  • Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Pharm Soc Jpn 1961;9:866–72
  • Kawabata Y, Yamamoto K, Debari K, et al. Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability. Eur J Pharm Sci 2010;39:256–62
  • Adibkia K, Barzegar-Jalali M, Maheri-Esfanjani H, et al. Physicochemical characterization of naproxen solid dispersions prepared via spray drying technology. Powder Technol 2013;246:448–55
  • Eloy JO, Marchetti JM. Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: a comparative study of fusion and solvent methods. Powder Technol 2014;253:98–106
  • Okologi S, Oguchi T, Yonemochi E, et al. Improved dissolution of ofloxacin via solid dispersion. Int J Pharm 1997;156:175–80
  • Chauhan H, Gu CH, Atef E. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J Pharm Sci 2013;102:1924–35
  • Guo Y, Shalaev E, Smith S. Physical stability of pharmaceutical formulations: solid-state characterization of amorphous dispersions. Trends Anal Chem 2013;49:137–44
  • Vishweshwar P, Mcmahon JA, Bis JA, Zaworotko MJ. Pharmaceutical co-crystals. J Pharm Sci 2006;95:499–516
  • Aakeröy CB. Crystal engineering: strategies and architectures. Acta Cryst B 1997;53:569–86
  • Hickey MB, Peterson ML, Scoppettuolo LA. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur J Pharm Biopharm 2007;67:112–19
  • Basavoju S, Boström D, Velaga SP. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization. Pharm Res 2008;25:530–41
  • Niu X, Wan L, Hou Z, et al. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability. Int J Pharm 2013;452:382–9
  • Sarodea AL, Malekara SA, Cotec C, Worthena DR. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine. Carbohydr Polym 2014;112:512–19
  • Badens E, Majerik V, Horvath G, et al. Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologies. Int J Pharm 2009;377:25–34
  • Marsac PJ, Li T, Taylor LS. Estimation of drug–polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 2009;26:139–51
  • Janssens S, Novoa de Armas H, D’Autry W, et al. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends. Eur J Pharm Biopharm 2008;69:1114–20
  • Huang J, Wigent RJ, Schwartz JB. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition. Drug Dev Ind Pharm 2006;32:1185–97
  • Baird JA, Eerdenbrugh BV, Taylor LS. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci 2010;99:3787–806
  • Marsac PJ, Konno H, Taylor LS. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm Res 2006;23:2306–16
  • Eerdenbrugh BV, Baird JA, Taylor LS. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation – classification and comparison with crystallization tendency from undercooled melts. J Pharm Sci 2010;99:3826–38
  • Avramov I, Zanotto ED, Prado MO. Glass-forming ability versus stability of silicate glasses. II. Theoretical demonstration. J Non-Cryst Solids 2003;320:9–20
  • Baird JA, Santiago-Quinonez D, Rinaldi C, Taylor LS. Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state. Pharm Res 2012;1:271–84
  • Willart JF, Descamps M. Solid state amorphization of pharmaceuticals. Mol Pharm 2008;5:905–20
  • Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12
  • Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev 2001;48:27–42
  • Weuts I, Kempena D, Verreck G, et al. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage. Eur J Pharm Sci 2005;25:387–93
  • Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res 2004;21:1762–9
  • Marsac PJ, Rumondor ACF, Nivens DE, et al. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly (vinyl pyrrolidone). J Pharm Sci 2010;99:169–85
  • Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS. Phase behavior of amorphous molecular dispersions I: determination of the degree and mechanism of solid solubility. Pharm Res 2004;21:1598–606
  • Khougaz K, Clas SD. Crystallization inhibition in solid dispersions of MK-0591 and poly (vinylpyrrolidone) polymers. J Pharm Sci 2000;89:1325–34
  • Gupta P, Bansal AK. Molecular interactions in celecoxib-PVP-meglumine amorphous system. J Pharm Pharmacol 2005;57:303–10
  • Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R. Inhibition of albendazole crystallization in poly (vinylpyrrolidone) solid molecular dispersions. Pharmazie 2006;61:618–24
  • Albers J, Alles R, Matthee K, et al. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur J Pharm Biopharm 2009;71:387–94
  • Gordon M, Taylor JS. Ideal copolymers and the 2nd-order transitions of synthetic rubbers 1. Non-crystalline copolymers. J Appl Chem 1952;2:493–500
  • Fox GT. Influence of diluent and copolymer composition on the glass transition temperature of a polymer system. Bull Am Phys Soc 1956;1:123
  • Couchman PR, Karasz FE. Classical thermodynamic discussion of effect of composition on glass-transition temperatures. Macromolecules 1978;11:117–19
  • Kwei T. The effect of hydrogen bonding on the glass transition temperatures of polymer mixtures. J Polym Sci Polym Lett Ed 2003;22:307–13
  • Kea P, Hasegawaa S, Al-Obaidib H, Buckton G. Investigation of preparation methods on surface/bulk structural relaxation and glass fragility of amorphous solid dispersions. Int J Pharm 2012;422:170–8
  • Bhattacharya S, Suryanarayana R. Local mobility in amorphous pharmaceuticals-characterization and implications on stability. J Pharm Sci 2009;98:2935–53
  • Vyazovkin S, Dranca I. Physical stability and relaxation of amorphous indomethacin. J Phys Chem B 2005;109:18637–44
  • Hancock BC, Shamblin SL, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures. Pharm Res 1995;12:799–806
  • Vyazovkin S, Dranca I. Effect of physical aging on nucleation of amorphous indomethacin. J Phys Chem B 2007;111:7283–7
  • Johari GP, Goldstein M. Molecular mobility in simple glasses. J Phys Chem 1970;74:2034–5
  • Rumondor ACF, Ivanisevic I, Bates S, et al. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res 2009;26:2523–34
  • Marsac PJ, Shamblin SL, Taylor LS. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006;23:2417–26
  • Zhu Q, Harris MT, Taylor LS. Time-resolved SAXS/WAXS study of the phase behavior and microstructural evolution of drug/PEG solid dispersions. Mol Pharm 2011;8:932–9
  • Ivanisevic I. Physical stability studies of miscible amorphous solid dispersions. J Pharm Sci 2010;99:4005–12
  • Verheyen S, Blaton N, Kinget R, Van den Mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45–58
  • Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1–11
  • Martınez-Oharriz MC, Martın C, Rodriguez- Espinosa C, et al. Influence of polyethylene glycol 4000 on the polymorphic forms of Diflunisal. Eur J Pharm Sci 1999;8:127–32
  • Sapkal S, Babhulkar M, Rathi A, et al. An overview on the mechanisms of solubility and dissolution rate enhancement in solid dispersion. Int J Pharm Tech Res 2013;5:31–9
  • Craig DQM, Newton JM. The dissolution of nortriptyline HCl from polyethylene glycol solid dispersions. Int J Pharm 1992;78:175–82
  • Sjokvist E, Nystrom C. Physicochemical aspects of drug release V1. Drug dissolution from solid particulate dispersions and the importance of carrier and drug particle properties. Int J Pharm 1991;69:53–62
  • Ohara T, Kitamura S, Kitagawa T, Terada K. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int J Pharm 2005;302:95–102
  • Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci 2009;98:2549–72
  • Chauhan H, Kuldipkumar A, Barder T, et al. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction. Pharm Res 2014;31:500–15
  • Prasad D, Chauhan H, Atef E. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug–polymer interaction for synergistic effects. J Pharm Sci 2014;103:3511–23
  • Terebetski JL, Michniak-Kohn B. Combining ibuprofen sodium with cellulosic polymers: a deep dive into mechanisms of prolonged supersaturation. Int J Pharm 2014;475:536–46
  • Bevernagea J, Brouwersa J, Brewsterb ME, Augustijns P. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. Int J Pharm 2013;453:25–35
  • Surana R, Pyne A, Suryanarayanan R. Effect of preparation method on physical properties of amorphous trehalose. Pharm Res 2004;21:1167–76
  • Lim RTY, Ng WK, Tan RBH. Dissolution enhancement of indomethacin via amorphization using co-milling and supercritical co-precipitation processing. Powder Technol 2013;240:79–87
  • Fecht HJ. Defect-induced melting and solid state amorphization. Nature 1992;356:133–5
  • Descamps M, Willart JF, Dudognon E, Caron V. Transformation of pharmaceutical compounds upon milling and comilling: the role of Tg. J Pharm Sci 2007;96:1398–407
  • Al-Obaidi H, Lawrence MJ, Shah S, et al. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions. Int J Pharm 2013;446:100–5
  • Gurunath S, Kumar SP, Basavaraj NK, Patil PA. Amorphous solid dispersion method for improving oral bioavailability of poorly water-soluble drugs. J Pharm Res 2013;6:476–80
  • Drooge DJV, Braeckmans K, Hinrichs W, et al. Characterization of the mode of incorporation of lipophilic compounds in solid dispersions at the nanoscale using fluorescence resonance energy transfer (FRET). Macromol Rapid Commun 2006;27:1149–55
  • Saers ES, Nystrom C, Alden M. Physicochemical aspects of drug release. XVI. The effect of storage on drug dissolution from solid dispersions and the influence of cooling rate and incorporation of surfactant. Int J Pharm 1993;90:105–18
  • Kolašinac N, Kachrimanis K, Homšek I, et al. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm 2012;436:161–70
  • Damian F, Blaton N, Naesens L, et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci 2000;10:311–22
  • Kalivoda A, Fischbach M, Kleinebudde P. Application of mixtures of polymeric carriers for dissolution enhancement of oxeglitazar using hotmelt extrusion. Int J Pharm 2012;439:145–56
  • Karata A, Yuksel N, Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. II Farmaco 2005;60:777–82
  • Li FQ, Hu JH, Deng JX, et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm 2006;324:152–7
  • Albertini B, Mezzena M, Passerini N, et al. Evaluation of spray congealing as technique for the preparation of highly loaded solid lipid microparticles containing the sunscreen agent, avobenzone. J Pharm Sci 2009;98:2759–69
  • Moyano-Mendez JR, Fabbrocini G, Stefano DD, et al. Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin. Drug Dev Ind Pharm 2014;40:1300–7
  • Goldberg AH, Gibaldi M, Kanig JL, Mayersohn M. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures IV: chloramphenicol-urea system. J Pharm Sci 1996;55:581–3
  • Passerini N, Qi S, Albertini B, et al. Solid lipid microparticles produced by spray congealing: influence of the atomizer on microparticle characteristics and mathematical modeling of the drug release. J Pharm Sci 2010;99:916–31
  • Owusu-Ababio G, Ebube NK, Reams R, Habib M. Comparative dissolution studies for mefenamic acid polyethylene glycol solid dispersion systems and tablets. Pharm Dev Technol 1998;3:405–12
  • Lin CW, Cham TM. Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions. Int J Pharm 1996;127:261–72
  • Yao WW, Bai TC, Sun JP, et al. Thermodynamic properties for the system of silybin and poly (ethylene glycol) 6000. Thermochim Acta 2005;437:17–20
  • Timko RJ, Lordi NG. Thermal characterization of citric acid solid dispersions with benzoic acid and phenobarbital. J Pharm Sci 1979;68:601–5
  • Breitenbach J, Lewis J. Two concepts, one technology: controlled release and solid dispersion with meltrex. In: Rathbone MJ, Hadgraft J, Roberts MS, Lane ME, eds. Modified-release drug delivery technology. New York: Marcel Dekker; 2003:125–34
  • Seo A, Holm P, Kristensen HG, Schafer T. The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer. Int J Pharm 2003;259:161–71
  • Gupta MK, Tseng TC, Goldman D, Bogner RH. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res 2002;19:1663–72
  • Andrew GP, Jones DS, Diak OA, et al. Hot-melt extrusion: an emerging drug delivery technology. Pharm Technol Eur 2009;21:24–7
  • Feng J, Xu L, Gao R, et al. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 2011;38:735–43
  • Djuris J, Nikolakakis I, Ibric S, et al. Preparation of carbamazepine-Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm 2013;84:228–37
  • Liu J, Cao F, Zhang C, Ping QN. Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm Sinica B 2013;3:263–72
  • Maniruzzaman M, Rana MM, Boateng JS, et al. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Drug Dev Ind Pharm 2013;39:218–27
  • Lang B, McGinity JW, Williams III RO. Hot-melt extrusion – basic principles and pharmaceutical applications. Drug Dev Ind Pharm 2014;40:1133–55
  • Das SK, Roy S, Kalimuthu Y, et al. Solid dispersions: an approach to enhance the bioavailability of poorly water-soluble drugs. Int J Pharm Pharm Tech 2012;1:37–46
  • Verhoeven E, De Beer T, Schacht E, et al. Influence of polyethylene glycol/polyethylene oxide on the release characteristics of sustained-release ethylcellulose mini-matrices produced by hot-melt extrusion: in vitro and in vivo evaluations. Eur J Pharm Biopharm 2009;72:463–70
  • Madan S, Madan S. Hot melt extrusion and its pharmaceutical applications. Asian J Pharm Sci 2012;7:123–33
  • Sarode AL, Sandhu H, Shah N, et al. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur J Pharm Sci 2012;48:371–84
  • Williams M, Tian Y, Jones DS, Andrews GP. Hot-melt extrusion technology: optimizing drug delivery. Eur Ind Pharm 2010;7:7–10
  • McGinity JW, Zhang F, Repka MA, Koleng JJ. Hot-melt extrusion as a pharmaceutical process. Am Pharm Rev 2001;4:25–36
  • Marin MT, Margarit MV, Salcedo GE. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. II Farmaco 2002;57:723–7
  • Dani P, Puri V, Bansal AK. Solubility advantage from amorphous etoricoxib solid dispersions. Drug Dev Ind Pharm 2014;40:92–101
  • Karavas E, Ktistis G, Xenakis A, Georgarakis E. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J Pharm Biopharm 2006;63:103–14
  • Yoshihashi Y, Iijima H, Yonemochi E, Terada K. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry. J Therm Anal Calorim 2006;85:689–92
  • Frizon F, de Oliveira Eloy J, Donaduzzi CM, et al. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Power Technol 2013;235:532–9
  • Planinsek O, Kovacic B, Vrecer F. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int J Pharm 2011;406:41–8
  • Hussain MD, Saxena V, Brausch JF, Talukder RM. Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance. Int J Pharm 2012;422:290–4
  • Tachibana T, Nakamura NA. A method for preparing an aqueous colloidal dispersion of beta-carotene by polyvinylpyrolidone. Colloid Polym Sci 1965;203:130–3
  • Ayad MA, Bonnet B, Quinton J, et al. Amorphous solid dispersion successfully improved oral exposure of ADX71943 in support of toxicology studies. Drug Dev Ind Pharm 2013;39:1300–5
  • Desai J, Alexander K, Riga A. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int J Pharm 2006;308:115–23
  • Li B, Konecke S, Wegiel LA. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices. Carbohydr Polym 2013;98:1108–16
  • Refat MS. Synthesis and characterization of ligational behavior of curcumin drug towards some transition metal ions: chelation effect on their thermal stability and biological activity. Spectrochim Acta Part A Mol Biomol Spectrosc 2013;105:326–37
  • Dhirendra K, Leiwis S, Udupa N, Atin K. Solid dispersion: a review. Pak J Pharm Sci 2009;22:234–46
  • Janssens S, Zeure AD, Paudel A, et al. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit E100. Pharm Res 2010;27:775–85
  • Zidana AS, Rahmana Z, Sayeeda V, et al. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis. Int J Pharm 2012;423:341–50
  • Zhao G, Duan J, Xie Y, et al. Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L. Drug Dev Ind Pharm 2013;39:1037–45
  • Yoshida T, Kurimoto I, Yoshihara K, et al. Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: evaluation of solid dispersion formulations. Int J Pharm 2012;428:18–24
  • Kojima Y, Ohta T, Shiraki K, et al. Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer. Drug Dev Ind Pharm 2013;39:1484–93
  • Shahzada Y, Sohailb S, Arshadb MS, et al. Development of solid dispersions of artemisinin for transdermal delivery. Int J Pharm 2013;457:197–205
  • Tong HHY, Du Z, Wang GN, et al. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. Int J Pharm 2011;404:148–58
  • Overhoff KA, Moreno A, Miller DA, et al. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing, Int J Pharm 2007;336:122–32
  • Kushida I, Gotoda M. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method. Drug Dev Ind Pharm 2013;39:1582–8
  • Dave RH, Patel HH, Donahue E, Patel AD. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole. Drug Dev Ind Pharm 2013;39:1562–72
  • Paudel A, Worku ZA, Meeus J, et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm 2013;453:253–84
  • Dobry DE, Settell DM, Baumann JM, et al. A model-based methodology for spray-drying process development. J Pharm Innov 2009;4:133–42
  • Cheow WS, Ng ML, Kho K, Hadinoto K. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Int J Pharm 2011;404:289–300
  • Overhoff KA, Engstrom JD, Chen B, et al. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs. Eur J Pharm Biopharm 2007;65:57–67
  • Shah N, Sandhu H, Phuapradit W, et al. Development of novel microprecipitated bulk powder (MBP) technology for manufacturing stable amorphous formulations of poorly soluble drugs. Int J Pharm 2012;438:53–60
  • Hu Q, Choi DS, Chokshi H, et al. Highly efficient miniaturized coprecipitation screening (MiCoS) for amorphous solid dispersion formulation development. Int J Pharm 2013;450:53–62
  • Albano A, Shah N, Sandhu H, et al. Solid complexes with ionic polymers. Innov Pharm Sci 2008;32:46–7
  • Thakkar FMVT, Soni TG, Gohel MC, Gandhi TR. Supercritical fluid technology: a promising approach to enhance the drug solubility. J Pharm Sci Res 2009;1:1–14
  • Gupta RG, Chatap VK, Gupta VB, et al. A review: supercritical fluid extraction technology. Pharm Rev 2008;6:1–6
  • Karanth H, Shenoy VS, Murthy RR. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report. AAPS PharmSciTech 2006;7:31–8
  • Shanbhag A, Rabel S, Nauka E, et al. Method for screening of solid dispersion formulations of low solubility compounds – miniaturization and automation of solvent casting and dissolution testing. Int J Pharm 2008;351:209–18
  • Chiang PC, Ran Y, Chou KJ, et al. Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery. AAPS PharmSciTech 2012;13:713–22
  • Lee TWY, Boersen NA, Yang G, Hui HW. Evaluation of different screening methods to understand the dissolution behaviors of amorphous solid dispersions. Drug Dev Ind Pharm 2014;40:1072–83
  • Shmeis RA, Wang Z, Krill SL. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part I: a comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry. Pharm Res 2004;21:2025–30
  • Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS. Phase behavior of amorphous molecular dispersions II: role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm Res 2005;22:440–8
  • Karavas E, Georgarakis M, Docoslis A, Bikiaris D. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix. Int J Pharm 2007;340:78–163
  • Lodge TP, Wood ER, Haley JC. Two calorimetric glass transitions do not necessarily indicate immiscibility: the case of PEO/PMMA. J Polym Sci 2005;44:756–63
  • Newman A, Engers D, Bates S, et al. Characterization of amorphous API: polymer mixtures using X-ray powder diffraction. J Pharm Sci 2008;97:4840–56
  • Ivanisevic I, Bates S, Chen P. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions. J Pharm Sci 2009;98:3373–86
  • Tobyn M, Brown J, Dennis AB, et al. Amorphous drug–PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state. J Pharm Sci 2009;98:3456–68
  • Forster A, Hempenstall J, Rades T. Characterisation of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmcol 2001;53:57–66
  • Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin–PVP solid dispersion obtained by spray drying. Int J Pharm 2004;271:281–6
  • Bates S, Zografi G, Engers D, et al. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res 2006;23:2333–49
  • Ouyang D. Investigating the molecular structures of solid dispersions by the simulated-annealing method. Chem Phys Lett 2012;554:177–84

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.